COVID-2019 vaccines - COVID-19 Vaccine Corporation
Alternative Names: SARS-CoV-2 vaccine – COVID-19 Vaccine CorporationLatest Information Update: 28 Jun 2024
At a glance
- Originator COVID-19 Vaccine Corporation
- Class COVID-19 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported COVID 2019 infections
Most Recent Events
- 28 Jun 2024 No recent reports of development identified for preclinical development in COVID-2019-infections(Prevention) in New Zealand (Parenteral)
- 09 Jul 2020 COVID-19 Vaccine Corporation signs a collaborative research agreement with Ardigen for development of vaccines for COVID-2019 infections (Prevention)
- 25 May 2020 Preclinical trials in COVID-2019 infections (Prevention) in New Zealand (Parenteral)